ARLG Study Employs Innovative Model to Test Diagnostics for Extragenital Gonorrhea
Molecular diagnostic assays have transformed the field of infectious diseases, allowing for swift and sensitive detection of organisms previously challenging to diagnose, but it can be difficult to study how these new tests perform. Members of the Antibacterial Resistance Leadership Group (ARLG), which is facilitated by the Duke Clinical Research Institute, recently conducted a study ... Read moreARLG joins forces with COMBACTE on a number of initiatives designed to fight drug-resistant infections
The U.S.-based Antibacterial Resistance Leadership Group (ARLG), part of the Duke Clinical Research Institute (DCRI) and the University Medical Center (UMC) Utrecht, the managing entity of the COMBACTE (Combatting Bacterial Resistance in Europe) consortium, will work together to solidify a comprehensive global community to combat the threat of antibiotic resistance around the world. “We at the ARLG have long admired the work being done by COMBACTE to increase the efficacy of antimicrobial drug development,” said Vance Fowler, MD, an investigator at the DCRI and co-principal investigator of the ARLG. “Combining our efforts will allow us to maximize the work we both do to stop the advancement of antibacterial resistance.” Read moreARLG at ECCMID
Support your ARLG colleagues who will be presenting at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam, Netherlands from April 13-16, 2019. Read moreMichael Woodworth, MD, MSc, receives the Southern Society for Clinical Investigation Research Scholar Award
Congratulations to Michael Woodworth, MD, MSc, for being selected as a recipient of the Southern Society for Clinical Investigation (SSCI) Research Scholar Award. This award provides funding for physician-scientists with innovative research projects related to internal medicine and its subspecialties. Dr. Woodworth will use the award to provide additional project funding for the ARLG ongoing ... Read more
ARLG In News:
NIH-Funded Antibacterial Resistance Leadership Group Details Progress, Challenges, NIAID, March 9, 2017
Report to The President on Combating Antibiotic Resistance, Whitehouse.gov, September 2014
White House references Duke leadership in antibiotic resistance, Duke Medicine News, September 19, 2014
Duke Leadership in Antibiotic Resistance Referenced in New Executive Action, DCRI, September 19, 2014
Fact Sheet: Obama Administration Takes Actions to Combat Antibiotic-Resistant Bacteria, Whitehouse.gov, September 18, 2014
ND4BB: Addressing The Antimicrobial Resistance Crisis, Nature Reviews Microbiology, March 10, 2014
NIAID Leadership Group for a Clinical Research Network on Antibacterial Resistance, NIAID, March 4, 2014
ARLG Research Network Will Target the Problem of Antibacterial Resistance, DCRI, November 8, 2013
Antibiotic Resistance in the News:
Diagnostic developers target antibiotic resistance : Nature News & Comment
Diagnostic developers target antibiotic resistance, Nature.com, October 9, 2015
NIH Funds Nine Antimicrobial Resistance Diagnostics Projects, NIAID, April 9, 2015
Obama battles 'superbugs' with national plan, CNN.com, March 27, 2015
Combating Antibiotic Resistance, FDA, October 14, 2014
National Strategy to Combat Antibiotic-Resistant Bacteria, CDC, September 22, 2014
New Executive Actions to Combat Antibiotic Resistance and Protect Public Health, Whitehouse.gov, September 18, 2014
Executive Order -- Combating Antibiotic-Resistant Bacteria, whitehouse.gov, September 18, 2014
PCAST Releases New Report on Combating Antibiotic Resistance, whitehouse.gov, September 18, 2014
Antimicrobial resistance, WHO, April 2014